Prudential Financial
CLVS

Prudential Financial’s Clovis Oncology, Inc. CLVS Stock Holding History

Prudential Financial’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-105,469
Closed -$3.1M – 2469
2018
Q3 		$3.1M Buy
105,469
+37,720
+56% +$1.46M ﹤0.01% 1413
2018
Q2 		$3.08M Buy
67,749
+7,640
+13% +$372K ﹤0.01% 1440
2018
Q1 		$3.17M Buy
60,109
+9,369
+18% +$547K ﹤0.01% 1357
2017
Q4 		$3.45M Sell
50,740
-15,820
-24% -$1.11M ﹤0.01% 1312
2017
Q3 		$5.49M Buy
66,560
+62,172
+1,417% +$4.93M 0.01% 1107
2017
Q2 		$411K Buy
4,388
+590
+16% +$36.1K ﹤0.01% 2072
2017
Q1 		$242K Buy
+3,798
New +$231K ﹤0.01% 2193
2016
Q1 		– Sell
-5,840
Closed -$204K – 2337
2015
Q4 		$204K Buy
5,840
+2,900
+99% +$187K ﹤0.01% 2153
2015
Q3 		$270K Buy
2,940
+200
+7% +$17.3K ﹤0.01% 2070
2015
Q2 		$241K Hold
2,740
– – ﹤0.01% 2099
2015
Q1 		$203K Buy
+2,740
New +$193K ﹤0.01% 2144
2014
Q4 		– Sell
-17,980
Closed -$816K – 2243
2014
Q3 		$816K Sell
17,980
-2,749
-13% -$115K ﹤0.01% 1787
2014
Q2 		$858K Buy
20,729
+14,049
+210% +$724K ﹤0.01% 1866
2014
Q1 		$532K Buy
+6,680
New +$491K ﹤0.01% 1934
2013
Q3 		– Sell
-4,089
Closed -$274K – 2318
2013
Q2 		$274K Buy
+4,089
New +$184K ﹤0.01% 2098

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Prudential Financial's CLVS Position: Q4 2018 in Review

Prudential Financial sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 105,469 shares — an estimated $3.1M sold.

Prudential Financial first reported a position in CLVS in Q2 2013 and held it in 15 quarters. The position peaked at $5.49M in Q3 2017. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • Prudential Financial reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • Prudential Financial sold 105,469 Clovis Oncology, Inc. shares in Q4 2018, an estimated $3.1M.
  • Prudential Financial first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 15 quarters.
  • Prudential Financial's Clovis Oncology, Inc. position peaked at $5.49M in Q3 2017.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Prudential Financial's 13F filing for Q4 2018, filed 7 Feb 2019.